National Cancer Institute: Building on Opportunities in Cancer Research 2016 describes current opportunities to build on and advance cancer research.Continue reading
Category Archives: AZBio News
Capstone Therapeutics Announces Phase 1b/2a Study Results for AEM-28 Showing Safety and Biomarker Efficacy Signals
Capstone Therapeutics (OTCQB:CAPS) (“the Company”) and its joint venture affiliate, LipimetiX Development, LLC (“JV”), announced today the completion of and results for its investigational AEM-28 (Apo E mimetic peptide) Phase 1b/2a human clinical trial in cholesterol and lipid reduction.Continue reading
D3Bio launches to support the growth of Arizona Bioscience Innovation and Innovators from discovery to development to delivery.
For immediate release:
December 15, 2014 – Chandler, Ariz.
D3Bio, a collaboration between the Opportunity Through Entrepreneurship Foundation (OTEF), an Arizona 501c3 corporation, and the Arizona Bioindustry Association, Inc. (AZBio), officially launched at AZBio Trailblazers on December 11, 2014. D3Bio will operate as a division under OTEF to support Life Science Innovation and Life Science Innovators in Arizona and across the Rocky Mountain Southwest Region.Continue reading
CellTrust closes $10.5M Series A Growth Funding Led by Kayne Partners
CellTrust® Corporation, a global leader in collaborative secure mobile communication with tracing and archiving capabilities, announced today that it has closed $10.5M in Series A funding from Kayne Partners, the growth private equity group of Kayne Anderson Capital Advisors, L.P. The growth capital investment will enable CellTrust to keep pace with customer demand, extend its infrastructure and expand its team.Continue reading
VisionGate® Wins Two Gold Awards in the Best in Biz Awards 2014
VisionGate, Inc. has been named a gold winner in two categories in the Best in Biz Awards 2014, the only independent business awards program judged by members of the press and industry analysts. VisionGate was awarded gold in the Most Innovative Company of the Year (Small) category and in the Most Innovative Product of the Year (SMB) category.Continue reading
New TGen test uses the unique genetics of women to uncover neurologic disorders
Study published today by investigators with TGen’s Dorrance Center for Rare Childhood DisordersContinue reading
Biopharmaceutical Companies Reaffirm Commitment to Patients in Updated Principles
By Dr. Bill Chin, PhRMA
Researchers in biopharmaceutical companies strive to discover and develop new medicines and vaccines that will help people to live longer, healthier lives. They go to work every day knowing that patients with life-threatening diseases live with the hope that tomorrow will bring a new medicine that will extend and improve lives.Continue reading
Critical Path Institute Receives Third Grant to Accelerate Tuberculosis Diagnostics
Multi-year grant to fund innovative global data platform designed to streamline tuberculosis diagnosis and treatment
CBR’s President and CEO Named as Founding Member of New Cord Blood Banking Association
Cord Blood Registry® (CBR®) announced today that Geoffrey Crouse, the company’s president and chief executive officer, is one of the 13 members of the founding board of The Cord Blood Association (CBA), a new trade and professional association organized for cord blood banking.Continue reading
Dr. Carolyn Compton and Caren Mason Join HealthTell’s Board of Directors
HealthTell™, an early stage Life Sciences company, announced that Carolyn Compton, M.D., Ph.D. and Caren Mason have joined the company’s Board of Directors. Compton brings over 30 years of leadership in pathology and life sciences to HealthTell, while Mason will offer her 20 years of senior executive experience across the public and private sector, building companies in life sciences, diagnostics, and medical devices.Continue reading